Di Federico, Alessandro; Filetti, Marco; Palladini, Arianna; Giusti, Raffaele; Piras, Marta; De Giglio, Andrea; Ardizzoni, Andrea; Gelsomino, Francesco, EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 497 - 503 [articolo]Open Access
Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melotti, Barbara, Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma, «CANCERS», 2022, 14, pp. 1 - 24 [articolo]Open Access
Ardizzoni, Andrea; Azevedo, Sergio; Rubio-Viqueira, Belen; Rodriguez-Abreu, Delvys; Alatorre-Alexander, Jorge; Smit, Hans J M; Yu, Jinming; Syrigos, Konstantinos; Höglander, Elen; Kaul, Monika; Tolson, Jonathan; Hu, Youyou; Vollan, Hans Kristian; Newsom-Davis, Thomas, Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2022, 10, Article number: e005581, pp. 1 - 5 [articolo]Open Access
Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Francesca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes, «CANCERS», 2022, 14, Article number: 3472, pp. 1 - 15 [articolo]Open Access
Donatella Romaniello, Valerio Gelfo, Federica Pagano, Enea Ferlizza, Michela Sgarzi, Martina Mazzeschi, Alessandra Morselli, Carmen Miano, Moshit Lindzen, Gabriele D’Uva, Francesco Fazi, Luca Tamagnone, Karim Rihawi, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola, IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization, in: ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, 2022, 126, pp. 117 - 117 (atti di: 75° Congresso Nazionale SIAI, Padova, 14-16 Settembre 2022) [Contributo in Atti di convegno]
De Giglio, Andrea; Aprile, Marta; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Gelsomino, Francesco; Ardizzoni, Andrea, Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC), «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 10292 - 10299 [articolo]Open Access
Ambrosi F.; Giunchi F.; Capizzi E.; Cancellieri A.; Trisolini R.; Ardizzoni A.; Fiorentino M.; Ricci C., Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples, «PATHOLOGY RESEARCH AND PRACTICE», 2022, 233, Article number: 153893, pp. 153893 - 153893 [articolo]
Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D.; Lamberti G., Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 1461, pp. 1461 - 1478 [articolo]Open Access
Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea, Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2022, 14, pp. * - * [articolo]Open Access
de Biase, Dario; Maloberti, Thais; De Leo, Antonio; Sanza, Viviana; Visani, Michela; Gruppioni, Elisa; Altimari, Annalisa; Grillini, Alessia; Gelsomino, Francesco; Ferrari, Marco; Ardizzoni, Andrea; Tallini, Giovanni, Next-generation technologies in predictive molecular pathology of lung cancers, «Journal of Xiangya Medicine», 2022, 7, pp. 1 - 13 [articolo]Open Access
Hayashi, Hidetoshi; Nadal, Ernest; Gray, Jhanelle E; Ardizzoni, Andrea; Caria, Nicola; Puri, Tarun; Grohe, Christian, Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations, «CLINICAL LUNG CANCER», 2022, 23, pp. 69 - 82 [articolo]Open Access
De Giglio, Andrea; Grandinetti, Valeria; Aprile, Marta; Borelli, Greta; Campus, Anita; Croci Chiocchini, Anna Laura; Busutti, Marco; Vischini, Gisella; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea; La Manna, Gaetano; Gelsomino, Francesco, Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience, «LUNG CANCER», 2022, 174, pp. 91 - 96 [articolo]
Santoro, Armando; Su, Wu-Chou; Navarro, Alejandro; Simonelli, Matteo; Ch Yang, James; Ardizzoni, Andrea; Barlesi, Fabrice; Hyoung Kang, Jin; DiDominick, Sarah; Abdelhady, Ahmed; Chen, Xueying; Stammberger, Uz; Felip, Enriqueta, Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer, «LUNG CANCER», 2022, 166, pp. 170 - 177 [articolo]Open Access
Ricci A.D.; Rizzo A.; Mollica V.; Schiavina R.; Fiorentino M.; Brunocilla E.; Ardizzoni A.; Massari F., Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data, «ANTI-CANCER DRUGS», 2022, 33, pp. e61 - e68 [articolo]
Sisi, Monia; Fusaroli, Michele; De Giglio, Andrea; Facchinetti, Francesco; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2022, 17, pp. 43 - 51 [articolo]Open Access
